ReShape Lifesciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Cash & Equivalents	4.56	3.96	22.82	3.01	14.06	21.19	21.11	72.98	3.36	6.9
Short-Term Investments	0	0	0	0	0	2.55	23.29	2.5	9.18	12.34
Cash & Cash Equivalents	4.56	3.96	22.82	3.01	14.06	23.74	44.4	75.48	12.53	19.24
Cash Growth	15.27%	-82.66%	658.73%	-78.61%	-40.78%	-46.54%	-41.17%	502.31%	-34.88%	-
Receivables	1.66	2.18	2.82	2.62	0.29	0.87	4.22	0.52	0.64	0.25
Inventory	3.74	3.61	3	2.24	1.94	1.58	1.42	0.83	0.36	0.45
Other Current Assets	0.34	0.17	1.31	1.07	1.96	2.46	1.71	1.24	0.27	0.29
Total Current Assets	10.3	9.91	29.94	8.94	18.24	28.65	51.76	78.06	13.8	20.24
Property, Plant & Equipment	0.31	0.87	1.72	1.05	2.16	1.74	1.35	0.72	0.42	0.48
Goodwill and Intangibles	0	0.26	20.83	27.02	0	0	0	0	0	0
Other Long-Term Assets	0.06	0.1	0.05	0.05	0	0	0	0	0	0
Total Long-Term Assets	0.37	1.23	22.59	28.12	2.16	1.74	1.35	0.72	0.42	0.48
Total Assets	10.66	11.14	52.53	37.06	20.39	30.39	53.1	78.78	14.22	20.72
Accounts Payable	1.69	1.93	3.47	3.66	0.65	1.16	1.28	0.6	0.55	0.18
Deferred Revenue	0	0	0	0	0.42	0.35	0.51	0.12	0	0
Current Debt	0.11	0.17	0.28	3.92	0.56	9.93	1.96	0	0.75	0
Other Current Liabilities	1.98	5.38	3.78	4.03	2.34	5.79	6.27	3.88	4.27	0.69
Total Current Liabilities	3.78	7.48	7.53	11.61	3.98	17.23	10.01	4.59	5.57	0.87
Long-Term Debt	0.15	0	0	9.33	0.57	0	7.96	9.88	9.09	4.88
Other Long-Term Liabilities	0.07	0	0.67	1.64	0	0.05	0.01	0	0	0
Total Long-Term Liabilities	0.22	0	0.67	10.97	0.57	0.05	7.98	9.88	9.09	4.88
Total Liabilities	4	7.48	8.2	22.57	4.54	17.28	17.99	14.47	14.66	5.75
Total Debt	0.26	0.17	0.28	13.25	1.13	9.93	9.92	9.88	9.84	4.88
Debt Growth	53.22%	-38.71%	-97.89%	1075.00%	-88.64%	0.08%	0.41%	0.41%	101.78%	-
Retained Earnings	-635.57	-624.19	-577.97	-514.83	-172.43	-148.75	-111.37	-76.61	-56.14	-40.59
Comprehensive Income	-0.09	-0.09	-0.09	-0.12	0	0	-0.01	-0	0	-0.01
Shareholders' Equity	6.66	3.66	44.33	14.49	15.85	13.11	35.11	64.31	-55.14	-39.86
Net Cash / Debt	4.3	3.78	22.54	-10.25	12.93	13.81	34.48	65.59	2.69	14.37
Net Cash / Debt Growth	13.56%	-83.21%	-	-	-6.36%	-59.96%	-47.44%	2338.44%	-81.28%	-
Net Cash Per Share	0.72	8.92	103.13	-131.21	411.98	1087.69	3093.58	23301.60	7041.88	40584.75
Working Capital	6.52	2.43	22.41	-2.66	14.26	11.42	41.74	73.47	8.24	19.36
Book Value Per Share	1.12	8.63	202.88	185.52	505.09	1032.73	3150.48	22839.71	-144297.60	-112496.68

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).